Literature DB >> 2557215

131I-metaiodobenzylguanidine (mIBG) for bronchial oat cell cancer and melanoma detection?

A Osei-Bonsu1, E M Kokoschka, W Ulrich, H Sinzinger.   

Abstract

The neuroendocrine features of bronchial oat cell carcinoma and melanoma indicate the possibility of positive imaging by means of radiolabelled metaiodobenzylguanidine. However, only four out of seven patients with bronchial oat cell carcinoma and three out of seven with melanoma were correctly diagnosed. Only false negative and no false positive results were obtained. The findings demonstrate a limited diagnostic value of the tracer in the tumor types examined.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2557215     DOI： 10.1007/BF00256943

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN： 0340-6997


  14 in total

1.  Failure of iodine-131 MIBG imaging in small cell lung carcinoma.

Authors:  M D Vincent; J Babich; A Irvine; V R McCready; I E Smith
Journal:  J Nucl Med       Date:  1987-07       Impact factor: 10.057

2.  Iodine-131 MIBG uptake in a small cell carcinoma of the lung.

Authors:  M Nakajo; M Taguchi; K Shimabukuro; S Shinohara
Journal:  J Nucl Med       Date:  1986-11       Impact factor: 10.057

3.  Specificity of iodobenzylguanidine scanning in neuroblastoma.

Authors:  J Pritchard; I Gordon; L Lashford; C Dicks-Mireaux
Journal:  Lancet       Date:  1988-02-27       Impact factor: 79.321

4.  Iodine-131 MIBG scintigraphy of neuroendocrine tumors other than pheochromocytoma and neuroblastoma.

Authors:  L Von Moll; A J McEwan; B Shapiro; J C Sisson; M D Gross; R Lloyd; E Beals; W H Beierwaltes; N W Thompson
Journal:  J Nucl Med       Date:  1987-06       Impact factor: 10.057

5.  Iodine-131 MIBG scintigraphy in small cell lung cancer.

Authors:  S Wadler; K Tai; L R Chervu; S Rafii; L Landau; M D Blaufox; P H Wiernik
Journal:  Eur J Nucl Med       Date:  1989

6.  Scintigraphic localization of phaeochromocytomas.

Authors:  M Fischer; W Vetter; B Winterberg; J Hengstmann; W Zidek; J Friemann; H Vetter
Journal:  Clin Endocrinol (Oxf)       Date:  1984-01       Impact factor: 3.478

7.  Monoclonal antibody HISL-19 as an immunocytochemical probe for neuroendocrine differentiation. Its application in diagnostic pathology.

Authors:  K Krisch; P Buxbaum; G Horvat; I Krisch; N Neuhold; W Ulrich; S Srikanta
Journal:  Am J Pathol       Date:  1986-04       Impact factor: 4.307

8.  Iodine-131 metaiodobenzylguanidine scintigraphy of carcinoid tumors.

Authors:  J M Feldman; R A Blinder; K J Lucas; R E Coleman
Journal:  J Nucl Med       Date:  1986-11       Impact factor: 10.057

9.  Meta-[I-131]iodobenzylguanidine uptake in a nonsecreting paraganglioma.

Authors:  A J Smit; L H van Essen; H Hollema; F A Muskiet; D A Piers
Journal:  J Nucl Med       Date:  1984-09       Impact factor: 10.057

10.  The use of 131I-MIBG in the imaging of metastatic carcinoid tumours.

Authors:  D I Jodrell; A T Irvine; V R McCready; E Woodcraft; I E Smith
Journal:  Br J Cancer       Date:  1988-11       Impact factor: 7.640
View more
  3 in total

1.  Indium-111 pentetreotide in the diagnostic work-up of patients with bronchogenic carcinoma.

Authors:  C M Kirsch; J von Pawel; I Grau; K Tatsch
Journal:  Eur J Nucl Med       Date:  1994-12

2.  Design, synthesis, and preliminary in vitro and in vivo evaluation of N-(2-diethylaminoethyl)-4-[18F]fluorobenzamide ([18F]-DAFBA): a novel potential PET probe to image melanoma tumors.

Authors:  Sudha Garg; Kanchan Kothari; Shankar R Thopate; Aniruddha K Doke; Pradeep K Garg
Journal:  Bioconjug Chem       Date:  2009-03-18       Impact factor: 4.774

Review 3.  Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours.

Authors:  C A Hoefnagel
Journal:  Eur J Nucl Med       Date:  1994-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.